Insulet (PODD) - Stock Price & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US45784P1012
Insulet Corporation, traded under the ticker symbol PODD on the NASDAQ, is a company that specializes in developing, manufacturing, and selling insulin delivery systems. Their primary focus is on providing innovative solutions for individuals living with insulin-dependent diabetes.
The flagship product of Insulet Corporation is the Omnipod System, a user-friendly, self-adhesive tubeless device that is designed to be worn on the body for up to three days. This system is accompanied by a wireless handheld personal diabetes manager which enhances the overall user experience.
Insulet Corporation distributes its products through a network of independent distributors and pharmacy channels, reaching customers not only in the United States but also in Canada, Europe, the Middle East, and Australia. This global presence reflects the company's commitment to making its cutting-edge technology accessible to individuals worldwide.
Established in 2000, Insulet Corporation is headquartered in Acton, Massachusetts, a testament to its roots in innovation and dedication to improving the lives of those managing diabetes. For more information, visit their website at https://www.insulet.com.
Drawdown (Underwater) Chart
Overall Trend and Yearly Seasonality
PODD Stock Overview
Market Cap in USD | 11,641m |
Sector | Healthcare |
Industry | Medical Devices |
GiC SubIndustry | Health Care Equipment |
TER | 0.00% |
IPO / Inception | 2007-05-15 |
PODD Stock Ratings
Growth 5y | 2.87 |
Fundamental | 25.6 |
Dividend | - |
Rel. Performance vs Sector | -7.23 |
Analysts | 4.41/5 |
Fair Price Momentum | 133.37 USD |
Fair Price DCF | 14.46 USD |
PODD Dividends
Yield 12m | 0.00% |
Yield on Cost 5y | 0.00% |
Dividends CAGR 5y | 0.00% |
Payout Consistency | 0.0% |
PODD Growth Ratios
Growth 12m | -48.09% |
Growth Correlation 12m | -47% |
Growth Correlation 3m | -49% |
CAGR 5y | 13.74% |
Sharpe Ratio 12m | -1.27 |
Alpha vs SP500 12m | -73.72 |
Beta vs SP500 5y weekly | 1.10 |
ValueRay RSI | 45.26 |
Volatility GJR Garch 1y | 38.84% |
Price / SMA 50 | -4.74% |
Price / SMA 200 | -13.17% |
Current Volume | 864.3k |
Average Volume 20d | 709.8k |
External Links for PODD Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X (Twitter) • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of April 27, 2024, the stock is trading at USD 164.17 with a total of 864,267 shares traded.
Over the past week, the price has changed by -0.34%, over one month by -0.35%, over three months by -17.37% and over the past year by -48.91%.
According to ValueRays Forecast Model, PODD Insulet will be worth about 148.5 in April 2025. The stock is currently trading at 164.17. This means that the stock has a potential downside of -9.53%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 236.8 | 44.3 |
Analysts Target Price | 257.9 | 57.1 |
ValueRay Target Price | 148.5 | -9.53 |